Location History:
- Dreieich, DE (2009 - 2016)
- Steinbach, DE (2024)
Company Filing History:
2 out of 4,804 
1 out of 1 
1 out of 1,827 
Years Active: 2009-2024
Title: **Klaus Scholich: Pioneering Innovations in Pain Treatment**
Introduction
Klaus Scholich, based in Dreieich, Germany, is a prominent inventor known for his significant contributions to the field of pain management. With a remarkable portfolio of four patents, he has made substantial strides in developing novel therapeutic approaches to alleviate various types of pain, particularly neuropathic pain.
Latest Patents
Scholich's groundbreaking patents primarily focus on innovative treatments for neuropathic pain. One of his latest inventions involves CYP2J2 antagonists in the treatment of chemotherapy-induced peripheral neuropathic pain (CIPNP). This invention introduces novel antagonists targeting cytochrome P450 epoxygenases (CYP), specifically CYP2J2, which have shown efficacy in reducing CIPNP in-vivo. This allows for higher dosing of chemotherapeutics during cancer treatments, providing significant benefits for patients suffering from cancer and other proliferative disorders.
In addition, another of his patents details methods for alleviating pain through the use of sphingosine-1-phosphate and related compounds. This method involves administering functional fragments and derivatives of sphingosine-1-phosphate, combined with assays for identifying effective compounds for pain relief. These innovations represent a substantial advancement in the treatment of pain-related disorders.
Career Highlights
Klaus Scholich has built a notable career working with esteemed organizations in the pharmaceutical and research sectors. He has contributed to the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a prestigious European research institution, as well as Sanofi-Aventis Pharma GmbH, where he has further honed his skills and expertise in the development of pain management therapies.
Collaborations
Throughout his career, Scholich has collaborated with distinguished professionals in the field, including Gerd Geisslinger and Martin Michaelis. These partnerships have enabled him to expand his research horizons and foster innovations that address complex medical challenges related to pain.
Conclusion
Klaus Scholich stands out as an influential inventor in the realm of pain treatment. With his innovative patents focusing on CYP2J2 antagonists and sphingosine-1-phosphate compounds, he continues to pave the way for new therapeutic options. His contributions not only enhance the understanding of pain mechanisms but also offer hope for improved patient care in oncology and beyond.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.